Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy
Crossref DOI link: https://doi.org/10.1007/s12072-015-9612-6
Published Online: 2015-03-12
Published Print: 2015-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ho, Edith Y.
Yau, Thomas
Rousseau, Franck
Heathcote, E. Jenny
Lau, George K. K.
Text and Data Mining valid from 2015-03-12